Cees G. M. Kallenberg

Articles in Scholarly Journals [Incomplete List]

  1. Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission
    Arthritis & Rheumatism, vol. 56, no. 6, pp. 2080–2091, 2007
  2. Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fc? receptor–dependent mechanism
    Arthritis & Rheumatism, vol. 56, no. 10, pp. 3399–3411, 2007
  3. Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome
    Arthritis & Rheumatism, vol. 56, no. 11, pp. 3588–3600, 2007
  4. Plasma kynurenine and related measures in tic disorder patients
    European Child & Adolescent Psychiatry, vol. 16, no. S9, pp. 71–77, 2007
  5. Influenza vaccination in systemic lupus erythematosus: Safe and protective?
    Autoimmunity Reviews, vol. 6, no. 5, pp. 300–305, 2007
  6. Opposed independent effects and epistasis in the complex association of IRF5 to SLE
    Genes and Immunity, vol. 8, no. 5, Article ID 6364407, 9 pages, 2007
  7. Inflammatory clearance of apoptotic cells after UVB challenge
    Autoimmunity, vol. 40, no. 4, pp. 244–248, 2007
  8. Use of mycophenolic acid in non-transplant renal diseases
    Nephrology Dialysis Transplantation, vol. 22, no. 4, pp. 1013–1019, 2007
  9. Staphylococcal toxic-shock-syndrome-toxin-1 as a risk factor for disease relapse in Wegener's granulomatosis
    Rheumatology, vol. 46, no. 6, pp. 1029–1033, 2007
  10. Comment on: parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's Syndrome: reply
    Rheumatology, vol. 46, no. 10, pp. 1625–1626, 2007
  11. Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus
    Rheumatology, vol. 46, no. 10, pp. 1551–1556, 2007
  12. Epstein-Barr Virus???DNA Load Monitoring Late After Lung Transplantation: A Surrogate Marker of the Degree of Immunosuppression and a Safe Guide to Reduce Immunosuppression
    Transplantation, vol. 83, no. 4, pp. 433–438, 2007
  13. Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis
    Current Opinion in Rheumatology, vol. 19, no. 1, p. 17???24, 2007
  14. Site-Specific Inhibition of Glomerulonephritis Progression by Targeted Delivery of Dexamethasone to Glomerular Endothelium
    Molecular Pharmacology, vol. 72, no. 1, pp. 121–131, 2007
  15. Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls
    Annals of the Rheumatic Diseases, vol. 66, no. 10, pp. 1350–1355, 2007
  16. Association of poly(ADP-ribose) polymerase 1 and a novel candidate locus, LOC127086, with systemic lupus erythematosus
    Annals of the Rheumatic Diseases, vol. 66, no. 3, pp. 424–426, 2007
  17. Relationship between blood hydroxychloroquine and desethylchloroquine concentrations and cigarette smoking in treated patients with connective tissue diseases
    Annals of the Rheumatic Diseases, vol. 66, no. 11, pp. 1547–1548, 2007
  18. Bosentan therapy for patients with severe Raynaud's phenomenon in systemic sclerosis
    Annals of the Rheumatic Diseases, vol. 66, no. 10, pp. 1398–1399, 2007
  19. Prognostic Value of Renal Hemodynamic Characteristics in Patients with Proliferative Lupus Nephritis
    Kidney and Blood Pressure Research, vol. 30, no. 3, pp. 175–181, 2007
  20. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus
    Arthritis Research & Therapy, vol. 9, no. 4, p. R84, 2007
  21. CD4-Positive Effector Memory T Cells Participate in Disease Expression in ANCA-Associated Vasculitis
    Annals of the New York Academy of Sciences, vol. 1107, no. 1, pp. 22–31, 2007
  22. EASI The European Autoimmunity Standardisation Initiative: A New Initiative that Can Contribute to Agreed Diagnostic Models of Diagnosing Autoimmune Disorders throughout Europe
    Annals of the New York Academy of Sciences, vol. 1109, no. 1, pp. 138–144, 2007
  23. Autoantibodies against Protective Molecules C1q, C-Reactive Protein, Serum Amyloid P, Mannose-Binding Lectin, and Apolipoprotein A1: Prevalence in Systemic Lupus Erythematosus
    Annals of the New York Academy of Sciences, vol. 1108, no. 1, pp. 227–239, 2007
  24. Regulation of Cytokine-Induced HIF-1  Expression in Rheumatoid Synovial Fibroblasts
    Annals of the New York Academy of Sciences, vol. 1108, no. 1, pp. 340–348, 2007
  25. Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus
    Lupus, vol. 15, no. 10, pp. 675–682, 2006
  26. European attempts to set guidelines for improving diagnostics of autoimmune rheumatic disorders
    Lupus, vol. 15, no. 7, pp. 391–396, 2006
  27. Quantitation of autoantibodies in systemic autoimmune diseases: clinically useful?
    Lupus, vol. 15, no. 7, pp. 397–402, 2006
  28. Plasma levels of soluble interleukin 2 receptor, soluble CD30, interleukin 10 and B cell activator of the tumour necrosis factor family during follow-up in vasculitis associated with proteinase 3-antineutrophil cytoplasmic antibodies: associations with disease activity and relapse
    Annals of the Rheumatic Diseases, vol. 65, no. 11, pp. 1484–1489, 2006
  29. Progression of salivary gland dysfunction in patients with Sjogren's syndrome
    Annals of the Rheumatic Diseases, vol. 66, no. 1, pp. 107–112, 2006
  30. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement
    Annals of the Rheumatic Diseases, vol. 65, no. 1, pp. 57–63, 2006
  31. Skin sensitivity to UVB irradiation in systemic lupus erythematosus is not related to the level of apoptosis induction in keratinocytes
    Rheumatology, vol. 45, no. 5, pp. 538–544, 2006
  32. Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment
    Rheumatology, vol. 45, no. 6, pp. 724–729, 2006
  33. Therapy-resistent lupus skin disease successfully treated with rituximab
    Rheumatology, vol. 45, no. 7, pp. 915–916, 2006
  34. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome
    Rheumatology, vol. 46, no. 2, pp. 335–341, 2006
  35. Parotid gland biopsy compared with labial biopsy in the diagnosis of Sjogren's syndrome: reply
    Rheumatology, vol. 46, no. 2, pp. 371–371, 2006
  36. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides
    Nature Clinical Practice Rheumatology, vol. 2, no. 12, Article ID ncprheum0355, 9 pages, 2006
  37. Persistent expansion of CD4+ effector memory T cells in Wegener's granulomatosis
    Kidney International, vol. 70, no. 5, Article ID 5001670, 9 pages, 2006
  38. Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis
    Arthritis & Rheumatism, vol. 54, no. 3, pp. 986–991, 2006
  39. Do apoptotic cells accumulate in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation? Comment on the article by Kuhn et al
    Arthritis & Rheumatism, vol. 54, no. 10, pp. 3373–3374, 2006
  40. Churg-Strauss syndrome: Just one disease entity?
    Arthritis & Rheumatism, vol. 52, no. 9, pp. 2589–2593, 2005
  41. Rituximab treatment in patients with primary Sjögren's syndrome: An open-label phase II study
    Arthritis & Rheumatism, vol. 52, no. 9, pp. 2740–2750, 2005
  42. Levels of complement in sera from inactive SLE patients, although decreased, do not influence in vitro uptake of apoptotic cells
    Journal of Autoimmunity, vol. 24, no. 4, pp. 329–336, 2005
  43. Plasma factors in severe early-onset preeclampsia do not substantially alter endothelial gene expression in vitro
    Journal of the Society for Gynecologic Investigation, vol. 12, no. 2, pp. 98–106, 2005
  44. Absence of In Vivo Generalized Pro-Inflammatory Endothelial Activation in Severe, Early-Onset Preeclampsia
    Journal of the Society for Gynecologic Investigation, vol. 12, no. 7, pp. 518–528, 2005
  45. Association of Common Cold with Exacerbations in Pediatric but not Adult Patients with Tic Disorder: AProspective Longitudinal Study
    Journal of Child and Adolescent Psychopharmacology, vol. 15, no. 2, pp. 285–292, 2005
  46. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease
    Annals of the Rheumatic Diseases, vol. 65, no. 7, pp. 913–918, 2005
  47. Accelerated atherosclerosis in patients with Wegener's granulomatosis
    Annals of the Rheumatic Diseases, vol. 64, no. 5, pp. 753–759, 2005
  48. Changes in salivary gland immunohistology and function after rituximab monotherapy in a patient with Sjogren's syndrome and associated MALT lymphoma
    Annals of the Rheumatic Diseases, vol. 64, no. 6, pp. 958–960, 2005
  49. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils
    Kidney International, vol. 68, no. 2, Article ID 4494623, 4 pages, 2005
  50. Activation, Apoptosis, and Clearance of Neutrophils in Wegener's Granulomatosis
    Annals of the New York Academy of Sciences, vol. 1051, no. 1, pp. 1–11, 2005
  51. Apoptosis in Human Skin: Role in Pathogenesis of Various Diseases and Relevance for Therapy
    Annals of the New York Academy of Sciences, vol. 1051, no. 1, pp. 52–63, 2005
  52. Accelerated Atherosclerosis in Patients with Systemic Autoimmune Diseases
    Annals of the New York Academy of Sciences, vol. 1051, no. 1, pp. 362–371, 2005
  53. Elevated Binding of D8/17-Specific Monoclonal Antibody to B Lymphocytes in Tic Disorder Patients
    American Journal of Psychiatry, vol. 161, no. 8, pp. 1501–1502, 2004
  54. Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti-PR3 antibodies
    Journal of Leukocyte Biology, vol. 76, no. 6, pp. 1162–1170, 2004
  55. B cell epitope specificity in ANCA-associated vasculitis: does it matter?
    Clinical and Experimental Immunology, vol. 137, no. 3, pp. 451–459, 2004
  56. Serum amyloid P component levels are not decreased in patients with systemic lupus erythematosus and do not rise during an acute phase reaction
    Annals of the Rheumatic Diseases, vol. 63, no. 7, pp. 831–835, 2004
  57. Relative Contribution of Attention-Deficit Hyperactivity Disorder, Obsessive-Compulsive Disorder, and Tic Severity to Social and Behavioral Problems in Tic Disorders
    Journal of Developmental & Behavioral Pediatrics, vol. 25, no. 4, pp. 272–279, 2004
  58. Interstitial nephritis with infiltration of IgG-kappa positive plasma cells in a patient with Sjogren's syndrome
    Rheumatology, vol. 43, no. 1, pp. 108–110, 2004
  59. Molecular genetic analyses of human NKG2C (KLRC2) gene deletion
    International Immunology, vol. 16, no. 1, pp. 163–168, 2004
  60. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis
    Nephrology Dialysis Transplantation, vol. 19, no. 6, pp. 1412–1419, 2004
  61. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis
    Nephrology Dialysis Transplantation, vol. 19, no. 11, pp. 2761–2768, 2004
  62. Neurobiology and neuroimmunology of Tourette?s syndrome: an update
    Cellular and Molecular Life Sciences (CMLS), vol. 61, no. 7-8, pp. 886–898, 2004
  63. The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages
    Arthritis & Rheumatism, vol. 50, no. 8, pp. 2667–2674, 2004
  64. Smoking and increased apoptosis in patients with systemic lupus erythematosus: Comment on the article by Costenbader et al
    Arthritis & Rheumatism, vol. 50, no. 11, pp. 3733–3733, 2004
  65. Comparison of Lacrimal and Salivary Gland Involvement in Sjogren's Syndrome
    Archives of Otolaryngology - Head and Neck Surgery, vol. 129, no. 9, pp. 966–971, 2003
  66. Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages
    Arthritis & Rheumatism, vol. 48, no. 1, pp. 248–254, 2003
  67. Role of the Fc? receptor IIA polymorphism in the antiphospholipid syndrome: An international meta-analysis
    Arthritis & Rheumatism, vol. 48, no. 7, pp. 1930–1938, 2003
  68. Staphylococcal superantigens and T cell expansions in Wegener's granulomatosis
    Clinical and Experimental Immunology, vol. 132, no. 3, pp. 496–504, 2003
  69. Fcgamma receptors in the initiation and progression of systemic lupus erythematosus
    Immunology and Cell Biology, vol. 81, no. 5, pp. 382–389, 2003
  70. Diversity of PR3-ANCA Epitope Specificity in Wegener's Granulomatosis. Analysis Using the Biosensor Technology
    Journal of Clinical Immunology, vol. 23, no. 6, pp. 460–468, 2003
  71. Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis
    Journal of Immunological Methods, vol. 274, no. 1-2, pp. 27–35, 2003
  72. Increased seroreactivity in tic disorder patients to a 60 kDa protein band from a neuronal cell line
    Journal of Neuroimmunology, vol. 141, no. 1-2, pp. 118–124, 2003
  73. Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study
    Rheumatology, vol. 43, no. 2, pp. 174–180, 2003
  74. Mycophenolate mofetil prevents a clinical relapse in patients with systemic lupus erythematosus at risk
    Annals of the Rheumatic Diseases, vol. 62, no. 6, pp. 534–539, 2003
  75. The Th1 and Th2 Paradigm in ANCA-Associated Vasculitis
    Kidney and Blood Pressure Research, vol. 26, no. 4, pp. 215–220, 2003
  76. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies
    Journal of Leukocyte Biology, vol. 74, no. 1, pp. 3–15, 2003
  77. Recombinant Protein to Analyze Autoantibodies to Proteinase 3 in Systemic Vasculitis
    American Journal of Clinical Pathology, vol. 120, no. 4, pp. 586–595, 2003
  78. Arthritis Research, vol. 4, no. 2, p. 77, 2002
  79. Fatigue and immune activity in Sjogren's syndrome
    Annals of the Rheumatic Diseases, vol. 61, no. 3, pp. 284–284, 2002
  80. Neutrophil Membrane Expression of Proteinase 3 (PR3) Is Related to Relapse in PR3-ANCA-Associated Vasculitis
    Journal of the American Society of Nephrology, vol. 13, no. 9, pp. 2232–2238, 2002
  81. Expression of recombinant proteinase 3, the autoantigen in Wegener's granulomatosis, in insect cells
    Journal of Immunological Methods, vol. 264, no. 1-2, pp. 195–205, 2002
  82. New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis
    Autoimmunity Reviews, vol. 1, no. 1-2, pp. 61–66, 2002
  83. Is Tourette’s syndrome an autoimmune disease?
    Molecular Psychiatry, vol. 7, no. 5, pp. 437–445, 2002
  84. Interference of PR3-ANCA with the enzymatic activity of PR3: differences in patients during active disease or remission of Wegener's granulomatosis
    Clinical and Experimental Immunology, vol. 129, no. 3, pp. 562–570, 2002
  85. Dying neutrophils in ANCA-associated vasculitis: Good or bad guys?
    Kidney International, vol. 61, no. 2, pp. 758–759, 2002
  86. Parotid sialography for diagnosing Sjögren syndrome
    Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology & Endodontics, vol. 94, no. 1, pp. 131–137, 2002
  87. IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus
    Rheumatology, vol. 41, no. 1, pp. 62–67, 2002
  88. The measurement of serum salivary isoamylase as a clinical parameter in Sjogren's syndrome
    Rheumatology, vol. 41, no. 6, pp. 706–708, 2002
  89. Fc? receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: Contribution ofFCGR2B to genetic susceptibility
    Arthritis & Rheumatism, vol. 46, no. 5, pp. 1242–1254, 2002
  90. In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase
    Arthritis & Rheumatism, vol. 46, no. 7, pp. 1894–1904, 2002
  91. The R-H polymorphism of FC? receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter
    Arthritis & Rheumatism, vol. 46, no. 4, pp. 1125–1126, 2002
  92. Familial Occurrence of Autoimmune Diseases and Autoantibodies in a Caucasian Population of Patients with Systemic Lupus Erythematosus
    Clinical Rheumatology, vol. 21, no. 2, pp. 108–113, 2002
  93. Clinical aspects of primary vasculitis
    Springer Seminars in Immunopathology, vol. 23, no. 3, pp. 231–252, 2001
  94. Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite-modified proteins and reactive oxygen species in Wegener's granulomatosis
    The Journal of Pathology, vol. 193, no. 2, pp. 224–232, 2001
  95. Simultaneous presentation of sarcoidosis and Sjogren's syndrome
    Rheumatology, vol. 40, no. 1, pp. 113–115, 2001
  96. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: Epitope analysis using synthetic peptides
    Kidney International, vol. 59, no. 1, pp. 147–159, 2001
  97. Comment
    Scandinavian Journal of Rheumatology, vol. 30, no. 3, pp. 127–128, 2001
  98. Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytes
    European Journal of Clinical Investigation, vol. 31, no. 6, pp. 550–553, 2001